Literature DB >> 23520595

Advancing addiction treatment: what can we learn from animal studies?

Peter H Wu1, Kalynn M Schulz.   

Abstract

Substance addiction is a maladaptive behavior characterized by compulsive and uncontrolled self-administration of a substance (drug). Years of research indicate that addictive behavior is the result of complex interactions between the drug, the user, and the environment in which the drug is used; therefore, addiction cannot simply be attributed to the neurobiological actions of a drug. However, despite the obvious complexity of addictive behavior, animal models have both advanced understanding of addiction and contributed importantly to the development of medications to treat this disease. We briefly review recent animal models used to study drug addiction and the contribution of data generated by these animal models for the clinical treatment of addictive disorders.

Entities:  

Mesh:

Year:  2012        PMID: 23520595      PMCID: PMC7802088          DOI: 10.1093/ilar.53.1.4

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  133 in total

1.  Open-label pilot study of bupropion plus bromocriptine for treatment of cocaine dependence.

Authors:  Ivan D Montoya; Kenzie L Preston; Richard Rothman; David A Gorelick
Journal:  Am J Drug Alcohol Abuse       Date:  2002       Impact factor: 3.829

2.  Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory.

Authors:  Courtney A Miller; John F Marshall
Journal:  Neuron       Date:  2005-09-15       Impact factor: 17.173

Review 3.  The genetics of addictions: uncovering the genes.

Authors:  David Goldman; Gabor Oroszi; Francesca Ducci
Journal:  Nat Rev Genet       Date:  2005-07       Impact factor: 53.242

Review 4.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

Review 5.  Proteins interacting with monoamine transporters: current state and future challenges.

Authors:  Jonathan J Sager; Gonzalo E Torres
Journal:  Biochemistry       Date:  2011-08-05       Impact factor: 3.162

6.  Genetics as a tool in alcohol research.

Authors:  G E McClearn
Journal:  Ann N Y Acad Sci       Date:  1972-05-25       Impact factor: 5.691

Review 7.  Nalmefene for treatment of alcohol dependence.

Authors:  Michael Soyka; Susanne Rösner
Journal:  Expert Opin Investig Drugs       Date:  2010-09-25       Impact factor: 6.206

8.  Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.

Authors:  Y Yoshida; S Koide; N Hirose; K Takada; K Tomiyama; N Koshikawa; A R Cools
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

9.  Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications.

Authors:  Xiao-Qing Peng; Zheng-Xiong Xi; Xia Li; Krista Spiller; Jie Li; Lauren Chun; Kuo-Ming Wu; Mark Froimowitz; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2010-09-08       Impact factor: 7.853

10.  Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide.

Authors:  R Ciccocioppo; I Panocka; C Polidori; R Froldi; S Angeletti; M Massi
Journal:  Pharmacol Biochem Behav       Date:  1998-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.